Search
Dofequidar
go.drugbank.com/drugs/DB14067InvestigationalDofequidar is an antineoplastic agent.
Categories: P-glycoprotein inhibitorsLufepirsen
go.drugbank.com/drugs/DB14915InvestigationalCODA-001 is under investigation in clinical trial NCT01165450 (Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects).
Hetrombopag
go.drugbank.com/drugs/DB16184InvestigationalHetrombopag is under investigation in clinical trial NCT03976882 (Hetrombopag for the Treatment of Chemotherapy-induced Thrombocytopenia in Subjects With Malignancy.).
Mavelertinib
go.drugbank.com/drugs/DB16228InvestigationalMavelertinib is under investigation in clinical trial NCT02349633 (Study for Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M)).
Synonyms: Egfr t790m inhibitor pf-06747775DTx-1252
go.drugbank.com/drugs/DB18086ExperimentalDTx-1252 is a siRNA therapeutic under investigation for the treatment of Charcot-Marie-Tooth Disease type 1A (CMTD1A).[L48096]
CSIC002
go.drugbank.com/drugs/DB18584ExperimentalIt is being investigated for the treatment of anterior ischemic optic neuropathy.
Timolumab
go.drugbank.com/drugs/DB18597InvestigationalTimolumab is a recombinant, fully-human, IgG4 immunoglobulin with antigen-binding specificity for human vascular adhesion protein-1 (VAP-1).
Synonyms: recombinant, fully-human, IgG4 immunoglobulin with antigen-binding specificity for human vascular adhesion protein-1 (VAP-1)